Hvivo

Hvivo company information, Employees & Contact Information

Explore related pages

Related company profiles:

hVIVO plc (Ticker: HVO) is full-service Contract Research Organisation (CRO) and the global leader in human challenge trials. The company delivers end-to-end clinical development services to a diverse and expanding client base, including seven of the world's ten largest biopharma companies. hVIVO specialises in conducting human challenge trials across multiple infectious and respiratory indications, leveraging its state-of-the-art quarantine facility in London-the largest of its kind worldwide. The company also offers comprehensive virology and immunology laboratory services under the hLAB brand. Through its German subsidiary, CRS, hVIVO operates a 120-bed capacity across Mannheim and Kiel, providing early-phase clinical trial services, including first-in-human and proof-of-concept studies. Its second subsidiary, Venn Life Sciences, offers Early Drug Development Consulting and Biometry services to the biopharma sector. The Group provides fully integrated drug development solutions from preclinical stages through Phase II trials, alongside patient recruitment via FluCamp. Additionally, its five clinical sites support outpatient Phase II and III trials, ensuring a seamless and efficient pathway from discovery to late-stage development.
Looking for a particular Hvivo employee's phone or email?

Hvivo Questions

News

Cidara and hVIVO report positive results in flu prevention study - PharmaTimes

Cidara and hVIVO report positive results in flu prevention study PharmaTimes

Role of human infection challenge studies (HICs) in drug development for respiratory syncytial virus (RSV): systematic review and meta-analysis - The Lancet

Role of human infection challenge studies (HICs) in drug development for respiratory syncytial virus (RSV): systematic review and meta-analysis The Lancet

Shaun Chilton appointed as hVIVO Non-Executive Chair - Pharmafile

Shaun Chilton appointed as hVIVO Non-Executive Chair Pharmafile

hVIVO acquires Germany’s CRS for ‘significant European foothold’ - BioXconomy

hVIVO acquires Germany’s CRS for ‘significant European foothold’ BioXconomy

hVIVO CEO on growth plans and human challenge trials - ICYMI - Proactive Investors

hVIVO CEO on growth plans and human challenge trials - ICYMI Proactive Investors

hVIVO PLC (AIM:HVO) Annual Report, Notice of AGM & Directorate Change - Share Talk

hVIVO PLC (AIM:HVO) Annual Report, Notice of AGM & Directorate Change Share Talk

Hvivo revenue falls as pharma market uncertainty hits - The Irish Times

Hvivo revenue falls as pharma market uncertainty hits The Irish Times

Hvivo shares tank after contract cancellations, 30 May 2025 11:40 - Shares Magazine

Hvivo shares tank after contract cancellations, 30 May 2025 11:40 Shares Magazine

Hvivo suffers half-year revenue slump - Business Post

Hvivo suffers half-year revenue slump Business Post

Should I buy penny stock hVIVO after its fall to 10p? - Fool UK

Should I buy penny stock hVIVO after its fall to 10p? Fool UK

HVivo trading in line with expectations with early success in diversification strategy - Proactive Investors

HVivo trading in line with expectations with early success in diversification strategy Proactive Investors

Shares in Hvivo nosedive as it loses key contract and postpones another - The Irish Times

Shares in Hvivo nosedive as it loses key contract and postpones another The Irish Times

hVIVO Appoints Shaun Chilton as Non-Executive Chair to Drive Growth - TipRanks

hVIVO Appoints Shaun Chilton as Non-Executive Chair to Drive Growth TipRanks

hVIVO PLC (AIM:HVO) Positive results from client Phase 2b field study - Share Talk

hVIVO PLC (AIM:HVO) Positive results from client Phase 2b field study Share Talk

‘He gets bored easily’: Hvivo pays tribute to Cathal Friel following co-founder’s exit - Business Post

‘He gets bored easily’: Hvivo pays tribute to Cathal Friel following co-founder’s exit Business Post

hVIVO CEO on record FY24 revenue & EBITDA as expansion strategy pays off - Proactive Investors

hVIVO CEO on record FY24 revenue & EBITDA as expansion strategy pays off Proactive Investors

Hvivo appoints Shaun Chilton as new non-executive chair - Business Post

Hvivo appoints Shaun Chilton as new non-executive chair Business Post

hVIVO: Numbers starting to stack up, says broker - Proactive Investors

hVIVO: Numbers starting to stack up, says broker Proactive Investors

hVIVO CEO Mo Khan on strategic Cryostore acquisition - Proactive Investors

hVIVO CEO Mo Khan on strategic Cryostore acquisition Proactive Investors

Brokers back hVIVO's long-term vision - Proactive Investors

Brokers back hVIVO's long-term vision Proactive Investors

British CRO hVIVO reels in £16.8M clinical trial deal for RSV drug - Fierce Biotech

British CRO hVIVO reels in £16.8M clinical trial deal for RSV drug Fierce Biotech

Clinical trials group Hvivo expands into Germany with €10m acquisition - The Irish Times

Clinical trials group Hvivo expands into Germany with €10m acquisition The Irish Times

hVIVO delivers promising results for Imutex’s mosquito vaccine - PharmaTimes

hVIVO delivers promising results for Imutex’s mosquito vaccine PharmaTimes

hVIVO plc – Unaudited Interim Results for Six Months Ended 30 June 2025 - Share Talk

hVIVO plc – Unaudited Interim Results for Six Months Ended 30 June 2025 Share Talk

hVIVO reports H1 revenue of £24.2m, eyes growth from new acquisitions and strong pipeline - Vox Markets

hVIVO reports H1 revenue of £24.2m, eyes growth from new acquisitions and strong pipeline Vox Markets

After falling 46% in a day, hVIVO’s become a penny stock… again! - Fool UK

After falling 46% in a day, hVIVO’s become a penny stock… again! Fool UK

hVIVO PLC (AIM:HVO) Trading update - Share Talk

hVIVO PLC (AIM:HVO) Trading update Share Talk

Contract research firm hVIVO sees revenues decline 32% - Irish Examiner

Contract research firm hVIVO sees revenues decline 32% Irish Examiner

hVIVO PLC (AIM:HVO) Director/PDMR Shareholding - Share Talk

hVIVO PLC (AIM:HVO) Director/PDMR Shareholding Share Talk

hVIVO contract increases confidence in medium-term order book, says broker - Proactive Investors

hVIVO contract increases confidence in medium-term order book, says broker Proactive Investors

hVIVO PLC (AIM:HVO) Trading update, Record performance in 2024 - Share Talk

hVIVO PLC (AIM:HVO) Trading update, Record performance in 2024 Share Talk

hVIVO PLC (AIM:HVO) Notice of Trading Update - Share Talk

hVIVO PLC (AIM:HVO) Notice of Trading Update Share Talk

Why we would stick with Hvivo despite share price fall - Shares Magazine

Why we would stick with Hvivo despite share price fall Shares Magazine

Hvivo chairman Cathal Friel sells remaining shares for €7.3m - The Irish Times

Hvivo chairman Cathal Friel sells remaining shares for €7.3m The Irish Times

hVIVO PLC (AIM:HVO) Appointment of Independent Non-Executive Director - Share Talk

hVIVO PLC (AIM:HVO) Appointment of Independent Non-Executive Director Share Talk

hVIVO: Brokers repeat 'buy' recommendations after acquisition and trading update - Proactive Investors

hVIVO: Brokers repeat 'buy' recommendations after acquisition and trading update Proactive Investors

Hvivo: Shaun Chilton - HealthInvestor UK

Hvivo: Shaun Chilton HealthInvestor UK

Markets Briefs: Accenture, Cairn, Hvivo and B&Q - Business Post

Markets Briefs: Accenture, Cairn, Hvivo and B&Q Business Post

Hvivo: Tracey James - HealthInvestor UK

Hvivo: Tracey James HealthInvestor UK

hVIVO plc (AIM: HVO) Appointment of Non-Executive Chair - Share Talk

hVIVO plc (AIM: HVO) Appointment of Non-Executive Chair Share Talk

Hvivo chief says market ‘looking better’ – despite 30% revenue slide - Business Post

Hvivo chief says market ‘looking better’ – despite 30% revenue slide Business Post

Is hVIVO’s share price crash a buying opportunity? - Investors' Chronicle

Is hVIVO’s share price crash a buying opportunity? Investors' Chronicle

HVIVO Announces New Major Holder - DirectorsTalk Interviews

HVIVO Announces New Major Holder DirectorsTalk Interviews

MIDAS SHARE TIPS: Revitalise your numbers with data gurus, ships and scientists - This is Money

MIDAS SHARE TIPS: Revitalise your numbers with data gurus, ships and scientists This is Money

Shares in Irish-founded Hvivo plummet 46% as clinical trials firm loses major contract - Business Post

Shares in Irish-founded Hvivo plummet 46% as clinical trials firm loses major contract Business Post

SEEK, hVIVO invest £14M to create universal flu vaccine joint venture - Fierce Biotech

SEEK, hVIVO invest £14M to create universal flu vaccine joint venture Fierce Biotech

Top Hvivo Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant